COVID-19 Antibody Cocktail Sweetens Regeneron’s Growth Story

 
• By Joseph Haas
Coronavirus dollar bill
REGEN-COV revenue has driven sales for Regeneron, but it has underlying growth too

More from Earnings

More from Business